Stock & Company Details
Immunome Inc $IMNM
Price:
N/A
N/A
114M
$2.2B
52 Week High:
N/A
10 Day Average Volume:
N/A
-7.74
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
IMNM technical indicators
Latest Immunome Inc (IMNM) indicator readings as of 2026-10-29.
IMNM's 14-day RSI is 39.9, in neutral territory. At $18.29 it is trading 18.7% below its 200-day moving average of $22.51, and below its 50-day average of $22.64. Price sits in the middle of its Bollinger Bands ($16.11 to $20.87). ADX reads 33.2, indicating a trending market.
Overview
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The company's primary focus areas are oncology and infectious disease, including COVID-19. It primarily operates in the U.S. Its current programs comprise Oncology (IMM-ONC-01), SARS-CoV-2 (IMM-BCP-01), and IMM20059 Anti-EPN1.
Finance Bot
Ask your questions
Start by typing a question below.
